| Date | Time | Source | Headline | Symbol | Company |
| 12/12/2018 | 7:14AM | Dow Jones News | Bausch Health Agrees to Buy Synergy Pharmaceuticals for $200 Million | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 12/12/2018 | 6:30AM | PR Newswire (US) | Bausch Health Enters Into Definitive "Stalking Horse" Agreement To Acquire Substantially All The Assets Of Synergy Pharmaceut... | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 12/12/2018 | 6:30AM | PR Newswire (Canada) | Bausch Health Enters Into Definitive "Stalking Horse" Agreement To Acquire Substantially All The Assets Of Synergy Pharmaceut... | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 12/12/2018 | 6:00AM | PR Newswire (US) | Synergy Pharmaceuticals Announces Agreement for Bausch Health to Acquire Its Business Assets | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 12/06/2018 | 4:35PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 11/26/2018 | 4:32PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 11/19/2018 | 6:09AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 11/15/2018 | 12:33PM | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 11/14/2018 | 6:55AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 11/09/2018 | 9:09AM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 11/09/2018 | 6:15AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 11/08/2018 | 5:00PM | Business Wire | Synergy Pharmaceuticals Reports Third Quarter 2018 Financial Results and Business Update | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 11/06/2018 | 5:16PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 11/01/2018 | 8:24AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 10/31/2018 | 5:00PM | Business Wire | Synergy Pharmaceuticals Names Dr. Melvin K. Spigelman Chairman | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 10/31/2018 | 6:17AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 10/25/2018 | 5:20PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 10/25/2018 | 5:00PM | Business Wire | Synergy Pharmaceuticals Provides Business Update | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 10/09/2018 | 6:14AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 10/08/2018 | 8:00AM | Business Wire | Synergy Pharmaceuticals Presents New Analyses Supporting the Use of TRULANCE® (plecanatide) in Two Patient Populations at th... | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 10/01/2018 | 5:02PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 10/01/2018 | 9:30AM | Business Wire | Synergy Pharmaceuticals to Present New Analyses of TRULANCE® (Plecanatide) at the American College of Gastroenterology (ACG)... | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 09/24/2018 | 8:17AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 09/24/2018 | 8:00AM | Business Wire | Synergy Pharmaceuticals Strengthens Coverage for TRULANCE® (plecanatide) with Key New Market Access Wins | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 09/21/2018 | 5:02PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 08/31/2018 | 5:02PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 08/16/2018 | 5:03PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 08/08/2018 | 1:15PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 08/07/2018 | 9:22PM | Business Wire | CORRECTING and REPLACING Synergy Pharmaceuticals Reports Second Quarter 2018 Financial Results and Business Update | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 08/07/2018 | 5:31PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |